Mechanism of 5-hydroxytryptamine-induced coronary vasodilatation assessed by direct detection of nitric oxide production in guinea-pig isolated heart

British Journal of Pharmacology

Volumn 119, Issue 4, 1996, Pages 721-729

  Ellwood, Amanda J ^a   Curtis, Michael J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

5 hydroxytryptamine; Coronary flow; Endothelial ablation; Nitric oxide

Indexed keywords

ACETYLCHOLINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROPRUSSIDE SODIUM; SAPONIN; SEROTONIN; SUBSTANCE P;

ANIMAL TISSUE; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; DIASTOLE; GUINEA PIG; HEART CONTRACTION; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; STARLING LAW; SYSTOLE; VASCULAR ENDOTHELIUM;

EID: 0029957525     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15732.x     Document Type: Article

References (45)

1. BEN-HARAI, R.R., DALTON, B.A., OSMAN. R. & MAAYANI, S (1991). Kinetic characterization of 5-hydroxytryptamine receptor desensitisation in isolated guinea-pig trachea and rabbit aorta. J. Pharmacol. Exp. Ther., 257, 416-424.
2. BENYO, Z., KISS, G., SZABO, C., CSAKI, C. & KOVACH, A.G.B. (1991). Importance of basal nitric oxide synthesis in regulation of myocardial blood flow. Cardiovasc. Res., 25, 700-703.
3. BROWNING, C., GILES, H. & MARTIN, G.R. (1995). The use of phenoxybenzamine to discriminate 5-HT receptors mediating endothelium-dependent and -independent vasoreluxation. Br. J. Pharmacol., 116, 262P.
4. G-nitro L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ. Res., 72, 387-395.
5. CHEN. G. & CHEUNG, D.W. (1992). Characterisation of acetylcholine-induced membrane hyperpolarisation in endothelial cells. Circ. Res., 70, 257-263.
6. 2 and 5-hydroxytryptamine receptor subtypes in human coronary arteries. Circulation, 87, 874-880.
7. COCKS, T.M. & ANGUS, J.A. (1983). Endothelium-dependent relaxation of coronary arteries by nonadrenaline and serotonin. Nature, 305, 627-630.
8. 2 receptor activation. Eur. J. Pharmacol., 161, 91-94.
9. CURTIS, M.J., MACLEOD, B.A., TABRIZCHI, R & WALKER, M.J.A. (1986). An improved perfusion apparatus for small animal hearts. J. Pharmacol. Methods, 15, 87-94.
10. ELLWOOD, A.J. & CURTIS, M.J. (1995). Effect of saponin versus L-NAME on the relationship between coronary flow and nitric oxide production under basal and agonist-stimulated conditions in guinea-pig isolated heart. Br. J. Pharmacol., 116, 62P.
11. ENOKIBORI, M., OKAMURA, T. & TODA, N. (1994). Mechanism of underlying substance P-induced relaxation in dog isolated superficial temporal arteries. Br. J. Pharmacol., 111, 77-82.
12. FURCHGOTT, R.F. (1983). Role of the endothelium in responses of vascular smooth muscle. Circ. Res., 53, 557-573.
13. FURCHGOTT, R.F. & ZAWADZKI, J.V. (1980). The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 286, 373-376.
14. GALINANES, M. & HEARSE, D.J. (1990). Species differences in susceptibility to ischémic injury and response to myocardial protection. Cardioscience, 2, 127-142.
15. GARLAND. C.J. & MCPHERSON, G.A. (1992). Evidence that nitric oxide does not mediate hyperpolarisation and relaxation to acetylcholine in the rat small mesenteric artery. Br. J. Pharmacol., 105,429-435.
16. GRIFFITH, T.M., HENDERSON, A.H., EDWARDS, D.H. & LEWIS, M.J. (1984). Coronary constriction: role of endothelium. J. Physiol., 351, 13-24.
17. IGNARRO, L.J., BYRNS, R.F., BUGA, G.M. & WOODS. K.S. (1987). Mechanisms of endothelium-dependent vascular smooth muscle relaxation elicited by bradykinin and VIP. Am. J. Physiol., 253, H1074-H1082.
18. KAUMANN, A.J., PARSONS, A.A. & BROWN, A.M. (1993). Human arterial constrictor serotonin receptors. Cardiovase. Res., 27, 2094-2103.
19. KELM, M. & SCHRADER, J. (1988). Nitric oxide release from isolated guinea-pig heart. Eur. J. Pharmacol., 155, 317-321.
20. KELM, M. & SCHRADER, J. (1990). Control of coronary vascular tone by nitric oxide. Circ. Res., 66, 1561-1575.
21. KILPATRICK, E.V. & COCKS, T.M. (1994). Evidence for differential roles of nitric oxide (NO) and hyperpolarisation in endothelium-dependent relaxation of pig coronary artery. Br. J. Pharmacol., 112, 557-565.
22. KLIMASCHEWSKI, L., KUMMER, W., MAYER, B., COURAUD, J.Y., PREISSLER, U., PHILIPPIN, B. & HEYN, C. (1992). Nitric oxide synthase in cardiac nerve fibres and neurones of rat and guinea-pig heart. Circ. Res., 71, 1533-1537.
23. KOMURA, T., LAMPING, K.G, EASTMAN, C.L., HARRISON, D.G., MARCUS, M.L. & DELLSPERGER, K.C. (1991). Effect of an arginine analogue on acetylcholine-induced coronary vascular dilatation in dogs. Am. J. Physiol., 261, H2001-H2007.
24. LEFROY, D.C., CRAKE, T., UREN, N.G, DAVIES, G.J & MASERI, A (1993). Effect of inhibition of nitric oxide synthase on epicardial coronary artery caliber and coronary blood flow in humans. Circulation, 88, 43-54.
25. LIPPTON, H.L., QINGZHONG, H. & HYMAN, A (1992). L-NAME enhances pulmonary vasoconstriction without inhibiting EDRF-dependent vasodilatation. Am. J. Physiol., 73, 2432-2439.
26. MANKAD, P.S., CHESTER, A.H. & YACOUB, M.H. (1991). 5-Hydroxytryptamine mediates endothelium-dependent coronary vasodilatation in the isolated rat heart by the release of nitric oxide. Cardiovasc. Res., 25, 244-248.
27. MCFADDEN, E.P., CLARKE, J.G., DAVIES, G.J., KASKI, J.C., HAIDER, A.W. & MASERI A. (1991). Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina. New Engl. J. Med., 324, 648-654.
28. MENON, M.K., WOLF, A., ZEHETGRUBER, M. & BING, R.J. (1989). An improved chemiluminescence assay suggests non nitric oxide-mediated action of lysophosphatidylcholine and acetylcholine. Proc. Soc. Exp. Med. Biol., 191, 316-319.
29. MONCADA, S., REES, D.D., SCHULZ, R. & PALMER. R.M.J (1991). Development and mechanism of a specific super sensitivity to nitrovasodilators after the inhibition of vascular nitric oxide synthesis in vivo. Proc. Natl. Acad. Sci. U.S.A., 88, 2166-2170.
30. OLSSON, R.A., BURINGER, R. & SPAAN, J.A.E (1992). Coronary circulation. In The Heart and Cardiovascular System: 2nd edition ed. Fozard, H.A., Haber, T., Jennings, R.B., Kutz, A.M. & Morgan, H.E. pp. 1393-1426. New York: Raven Press.
31. PABLA, R. & CURTIS. M.J (1995). Effects of nitric oxide modulation on cardiac arrhythmias in the rat isolated heart. Circ. Res., 77, 984-992.
32. PLANE, F., PEARSON, T. & GARLAND. C.J. (1995). Multiple pathways of underlying endothelial-dependent relaxation in the rabbit isolated femoral artery. Br. J. Pharmacol., 115, 31-38.
33. REES, D.D., PALMER, R.M.J., HODSON, H.F. & MONCADA, S (1989). A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br. J. Pharmacol., 96, 418-424.
34. REES, D.D., PALMER, R.M.J., SCHULZ. R., HODSON, H.F. & MONCADA, S. (1990). Characterisation of the three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol., 101, 746-752.
35. REES, S.A. & CURTIS, M.J. (1993). Selective IK blockade as an antiarrhythmic mechanism in ischaemic heart disease: Effects of UK 66-914 in the rat and rabbit. Br. J. Pharmacnl., 108, 139-145.
36. REN, L.M., NAKANE, T. & CHIBA, S. (1993). Muscarinic receptor subtypes mediating vasodilation and vasoconstriction in isolated, perfused simian coronary arteries. J. Cardiovasc. Pharmacol., 22, 841-846.
37. SAMATA, K., KIMURA, T, SATOH, S. & WATANABE, H. (1986). Chemical removal of the endothelium by saponin in the isolated dog femoral artery. Eur. J. Pharmacol., 128, 85-91.
38. SHIRASAKI, Y. & SU, C. (1985). Endothelium removal augments vasodilation by sodium nitroprusside and sodium nitrite. Eur. J. Pharmacol., 114,93-96.
39. SMITH, R.E.A., PALMER, R.M.J., BUCKNALL, C.A. & MONCADA, S (1992). Role of nitric oxide synthesis in the regulation of coronary vascular tone in the isolated perfused rabbit heart. Cardiovasc. Res., 26, 508-512.
40. TARE, M., PARKINGTON, H.C., COLEMAN, H.A., NEILD. T.O. & DUSTING, G.J. (1990). Hyperpolarisation and relaxation of arterial smooth muscle caused by nitric oxide derived from endothelium. Nature, 346, 69-71.
41. VANHOUTTE, P.M. (1991). Platelet-derived serotonin, the endothelium and cardiovascular disease. J. Cardiovasc. Pharmacol., 17 (supp 5), S6-S12.
42. WALDRON, G.J. & GARLAND, C.J. (1994). Contribution of both nitric oxide and a change in membrane potential in acetylcholineinduced relaxation in rat small mesenteric artery. Br. J. Pharmacol., 112, 831-836.
43. WARD, J.E. & ANGUS, J.A. (1993). Acute and chronic inhibition of nitric oxide synthase in conscious rabbits: Role of nitric oxide in the control of vascular tone. J. Cardiovasc. Pharmacol., 21, 804-814.
44. WIEST, E., TRACH, V. & DAMMGEN, J. (1989). Removal of endothelial function in coronary resistance vessels by saponin. Basic. Res. Cardiol., 84, 469-478.
45. XIE, H. & TRIGGLE, C.R. (1994). Endothelium-independent relaxations to acetylcholine and A23187 in human umbilical artery. J. Vase. Res., 31, 92-105.